Published in:
01-09-2019 | Response
Right to Try: In response
Published in: Journal of Bioethical Inquiry | Issue 3/2019
Login to get accessExcerpt
Oliver Kim’s (2019) criticisms of my article are a mixture of inaccuracies, non sequiturs, and terminological points.
(i)
He states that I defend the Right to Try laws.
(ii)
He states that I believe that patients have a right to access innovations “without interference by government agencies or institutional decision-makers.”
(iii)
He objects that my approach “does not weigh” the other rights at stake.
(iv)
He says that I have confused innovation with experimentation.
(v)
He complains that patients often fail to receive recommended treatments, let alone experimental or innovative therapies, and that Right to Try fails to address this problem.